Explore more publications!
Cincinnati Wellness Review
Got News to Share?

Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on December 19, 2025

Allegria Studio Brings Undetectable Permanent Makeup to Greater Cleveland
Dec. 19, 2025

Allegria Studio Brings Undetectable Permanent Makeup to Greater Cleveland

Indeterminate EIN Presswire
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
Dec. 19, 2025

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

Indeterminate GlobeNewswire
Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC
Dec. 19, 2025

Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC

Indeterminate GlobeNewswire
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec. 19, 2025

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Nyxoah Annonce L’Émission de la Première Tranche des Obligations Convertibles
Dec. 19, 2025

Nyxoah Annonce L’Émission de la Première Tranche des Obligations Convertibles

Indeterminate GlobeNewswire
Lifeward Appoints Bob Marshall as Chairman of the Board
Dec. 19, 2025

Lifeward Appoints Bob Marshall as Chairman of the Board

Indeterminate GlobeNewswire
NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
Dec. 19, 2025

NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis

Indeterminate GlobeNewswire
Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)
Dec. 19, 2025

Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)

Indeterminate GlobeNewswire
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Dec. 19, 2025

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Indeterminate GlobeNewswire
Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms
Dec. 19, 2025

Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms

Indeterminate GlobeNewswire
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
Dec. 19, 2025

U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults

Indeterminate GlobeNewswire
Third-Party Recognition Underscores Genesis Healthcare’s Ongoing Commitment to Excellence in Skilled Nursing Care
Dec. 19, 2025

Third-Party Recognition Underscores Genesis Healthcare’s Ongoing Commitment to Excellence in Skilled Nursing Care

Indeterminate GlobeNewswire
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Dec. 19, 2025

Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation

Indeterminate GlobeNewswire
Communiqué de presse : Sanofi conclut un accord avec le gouvernement américain pour réduire le coût des médicaments et renforcer l’innovation
Dec. 19, 2025

Communiqué de presse : Sanofi conclut un accord avec le gouvernement américain pour réduire le coût des médicaments et renforcer l’innovation

Indeterminate GlobeNewswire
Tevogen CEO Donates Personal Shares to Support Local Fire Department
Dec. 19, 2025

Tevogen CEO Donates Personal Shares to Support Local Fire Department

Indeterminate GlobeNewswire
Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman
Dec. 19, 2025

Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman

Indeterminate GlobeNewswire
OncoInv y MaxBloch se asocian para ampliar la detección temprana de cáncer en Centroamérica
Dec. 19, 2025

OncoInv y MaxBloch se asocian para ampliar la detección temprana de cáncer en Centroamérica

Indeterminate GlobeNewswire
OncoInv e MaxBloch firmam parceria para expandir a detecção precoce do câncer em toda a América Central
Dec. 19, 2025

OncoInv e MaxBloch firmam parceria para expandir a detecção precoce do câncer em toda a América Central

Indeterminate GlobeNewswire
Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements
Dec. 19, 2025

Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements

Indeterminate GlobeNewswire
NRPA Releases 2025 Engagement With Parks Report Highlighting Continued Public Demand
Dec. 19, 2025

NRPA Releases 2025 Engagement With Parks Report Highlighting Continued Public Demand

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions